Precigen, Inc. Banner Image

Precigen, Inc. has reached its limit for free report views

Work for Precigen, Inc.? Upgrade Your Profile and unlock all your annual reports.

Precigen, Inc.

  • Ticker PGEN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Precigen, Inc. Logo Image
  • 501-1000 Employees
  • Based in Germantown, Maryland
Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeuticsMore in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.
Precigen, Inc.

Most Recent Annual Report

Precigen, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Precigen, Inc. has reached its limit for free report views.